PTC Therapeutics and Invitae have partnered to launch a free genetic testing program that helps diagnose neurotransmitter…
David Melamed
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by David Melamed
A case study of a 3-month-old patient provided evidence to support the use of a urine organic acid analysis in…